Argenx SE (ARGX) | Stock Overview & Key Data
Argenx SE Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €810.00 on November 20, 2025
Explore how other BE stocks compare to their 52-week ranges: View BE Market 52-Week Insights
Key Statistics
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Argenx SE
ARGX
|
41.43B Large-cap | -0.26% | 9.81% | 24.18% | 24.18% | 24.18% | 29.01% | 29.01% | 29.01% | 29.01% | 29.01% | 29.01% |
|
UCB S.A
UCB
|
50.14B Large-cap | -0.69% | 9.37% | 1.69% | 8.86% | 10.67% | 68.19% | 220.47% | 222.73% | 332.23% | 618.13% | 618.13% |
|
Onward Medical N.V
ONWD
|
204.41M Mid-cap | -3.62% | -3.97% | -26.92% | -34.00% | -39.41% | -37.17% | -55.89% | -79.43% | -79.43% | -79.43% | -79.43% |
| N/A | -1.22% | 14.47% | 5.09% | 6.07% | 7.58% | 85.71% | 225.88% | 200.37% | 364.29% | 681.77% | 681.77% | |
|
Hyloris
HYL
|
152.32M Mid-cap | -5.80% | -9.77% | -21.24% | -20.97% | -34.40% | -18.10% | -59.05% | -65.07% | -55.10% | -55.10% | -55.10% |
|
European Medical
ALEMS
|
20.74M Small-cap | 1.63% | 2.04% | 1.01% | -7.41% | 6.84% | 6.38% | -16.39% | -95.91% | -99.74% | -99.78% | -99.78% |
Ownership & Short Interest
Calculate Your Argenx SE Investment Returns
Long-Term Investment Performance Analysis
Argenx SE stock price in Mar 2026 was €607.40, A €1,000.00 lump sum investment in Argenx SE made 0 years ago would be worth approximately €1,253.21 today, representing a positive return of 25.32%.
2 Months Investment Scenario (Mar 2026 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is ARGX's 52-week high and low?
- In the last 52 weeks, Argenx SE reached a high of €810.00 (on N/A) and a low of €456.60 (on N/A).
- What is the market cap and P/E ratio for ARGX?
- Curious about Argenx SE's size and valuation? Its market capitalization stands at 41.43B. When it comes to valuation, the P/E ratio (trailing twelve months) is 39.84, and the forward P/E (looking ahead) is 21.85.
- Does ARGX pay dividends? If so, what's the yield?
- As for dividends, Argenx SE isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Argenx SE's main competitors or similar companies to consider before investing?
When looking at Argenx SE, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return UCB S.A
UCB50.14B Healthcare Biotechnology 68.19% 220.47% Onward Medical N.V
ONWD204.41M Healthcare Biotechnology -37.17% -55.89% Financière de Tubize
TUBN/A Healthcare Biotechnology 85.71% 225.88% Hyloris
HYL152.32M Healthcare Biotechnology -18.10% -59.05% European Medical
ALEMS20.74M Healthcare Biotechnology 6.38% -16.39% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Argenx SE? (e.g., ROE, Debt/Equity)
- To get a sense of Argenx SE's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 20.15%, the Debt to Equity ratio from the most recent quarter is 0.64, and its Gross Profit Margin stands at 88.38%.
- What is the recent revenue and earnings growth for ARGX?
- Looking at Argenx SE's growth, its revenue over the trailing twelve months (TTM) was €4B. Compared to the same quarter last year (YoY), quarterly revenue grew by 73.00%, and quarterly earnings saw a YoY growth of -31.20%.
- How much of ARGX stock is held by insiders and institutions?
- Wondering who owns Argenx SE stock? Company insiders (like executives and directors) hold about 0.00% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 45.08%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.